Key result
Regional anesthesia and choice of anesthetic regimen did not affect overall or recurrence-free survival but were associated with fewer ICU transfers and shortened time to discharge.
Why the study?
Unlike in adults, limited data exist regarding the potential association of anesthesiologic interventions and blood product administration with outcomes in pediatric cancer patients.
Do anesthesiologic interventions (blood transfusion, regional anesthesia, anesthetic regimen) improve outcomes in pediatric patients undergoing surgery for nephroblastoma?
Cohort
Yes
Do anesthesiologic interventions (blood transfusion, regional anesthesia, anesthetic regimen) improve outcomes in pediatric patients undergoing surgery for nephroblastoma?
p-value: p=0.124
In pediatric nephroblastoma surgery, regional anesthesia and anesthetic choice do not appear to impact survival but may reduce ICU transfers and hospital length of stay.
Regional anesthesia should not yet change practice in pediatric nephroblastoma surgery; leaves open whether it reduces ICU transfers and length of stay.
BACKGROUND: Recent data suggest that anesthesiologic interventions-e.g., the choice of the anesthetic regimen or the administration of blood products-might play a major role in determining outcome after tumor surgery. In contrast to adult patients, only limited data are available regarding the potential association of anesthesia and outcome in pediatric cancer patients. METHODS: A retrospective multicenter study assessing data from pediatric patients (0-18 years of age) undergoing surgery for nephroblastoma between 2004 and 2018 was conducted at three academic centers in Europe. Overall and recurrence-free survival were the primary outcomes of the study and were evaluated for a potential impact of intraoperative administration of erythrocyte concentrates, the use of regional anesthesia and the choice of the anesthetic regimen. The length of stay on the intensive care unit, the time to hospital discharge after surgery and blood neutrophil-to-lymphocyte ratio were defined as secondary outcomes. RESULTS: = 0.124) was not affected. The use of regional anesthesia and the choice of anesthetic used for maintenance of anesthesia did not demonstrate an effect on the primary outcomes. It was, however, associated with fewer ICU transfers, a shortened time to discharge and a decreased postoperative neutrophil-to-lymphocyte ratio. CONCLUSIONS: The current study provides the first evidence for a possible association between blood transfusion as well as anesthesiologic interventions and outcome after pediatric cancer surgery.
No takes yet. Share an insight, caveat, or question.
Müller et al. (2022) conducted a cohort in Nephroblastoma. Intraoperative blood transfusion, regional anesthesia, and choice of anesthetic regimen was evaluated on Overall and recurrence-free survival (p=0.124). Regional anesthesia and choice of anesthetic regimen did not affect overall or recurrence-free survival but were associated with fewer ICU transfers and shortened time to discharge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: